Amsterdam - Delayed Quote EUR
Vivoryon Therapeutics N.V. (VVY.AS)
1.7200
-0.0340
(-1.94%)
As of 3:04:37 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-19,174
-19,174
-21,541
-21,794
-11,257
Investing Cash Flow
9,998
9,998
-10,514
-13
-28
Financing Cash Flow
-57
-57
24,157
33,381
-827
End Cash Position
9,365
9,365
18,562
26,555
14,661
Capital Expenditure
-2
-2
-514
-13
-28
Issuance of Capital Stock
0
0
26,346
36,000
1,144
Free Cash Flow
-19,176
-19,176
-22,055
-21,807
-11,285
12/31/2021 - 10/27/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1IJA.MU Adicet Bio Inc
0.5870
-4.24%
MARI.VI Marinomed Biotech AG
12.25
-0.81%
FYB.DE Formycon AG
22.90
-1.29%
BIOV.SW BioVersys N
34.70
0.00%
HPHA.DE Heidelberg Pharma AG
3.2500
+4.17%
VSC.F 4SC AG
2.4800
0.00%
MDG1.F Medigene AG
0.1100
-4.76%
ALTME.PA TME Pharma N.V.
0.0733
+1.81%
NYKD.OL Nykode Therapeutics AS
2.7040
-2.87%
FYB.F Formycon AG
23.05
-0.86%